Skip to content
SempreFit

SempreFit

AI-Driven Longevity Systems

Menu

  • Home
  • Start Assessment
  • Blog

Month: June 2023

Cell and gene therapy manufacturing: the next generation of startups

Cell and gene therapy manufacturing: the next generation of startups

At least six companies have emerged to help unstick what developers say is a “bottleneck” in advancing complex genetic treatments. Editor’s note: BioPharma Dive, as part of Emerging Biotech Weekly, is taking a closer look at competitive areas of startup activity. We aim

DCoello June 20, 2023September 18, 2024 Age hacking, reverse age Read more

The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule

anti-aging

In June 2018, the World Health Organization (WHO) released the 11th edition of its International Classification of Diseases and added aging for the first time. The classification of aging as a disease paves the way for new research into novel therapeutics to

DCoello June 7, 2023June 7, 2023 Journals Read more

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Abstract Leigh syndrome is a mitochondrial disease characterized by neurological disorders, metabolic abnormalities, and premature death. There is no cure for Leigh syndrome; therefore, new therapeutic targets are urgently needed. In Ndufs4-KO mice, a mouse model of Leigh syndrome, we

DCoello June 7, 2023September 18, 2024 Journals Read more

Building advanced longevity systems powered by peptides, regenerative science, and AI-driven optimization.

New York, NY 10013
929-423-0072

Resources

Copyright © 2026 SempreFit. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.
  • About
  • Blog
  • Contact
  • Research Use Only (RUO) Disclaimer